Evidence has shown the EVO ICL Lens (EVO) procedure to be an effective treatment for as low as -3.00 D of myopia.* Read more from Dr. Waring on what you can expect with patient outcomes by clicking the following link: https://bit.ly/3ZewFFv #STAAR #EVO #EVOICL #ophthalmology #ophthalmologist *Packer M. The EVO ICL for moderate myopia: results from the US FDA clinical trial. Clin Ophthalmol. 2022;16:3981-3991. The EVO ICL lens is an Rx Only surgical implant that corrects distance vision for persons 21 -– 45 years of age. Surgeons must be certified prior to use including training on contraindications, surgical procedure and potential benefits, risks, and complications of both the surgery and the lens. Click here for Important Safety Information: https://bit.ly/3zkV7ch
